FDA Investigator Russ E Davis

Russ E Davis has conducted inspections on 148 sites in 2 countries as of 19 Dec 2018. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
148
Last Inspection Date:
19 Dec 2018
Investigator Role:
FDA Investigator
Redica ID:
100003177
Countries of Inspections:
United States of America, India
FDA Investigators that have inspected at least one site in common with Russ E Davis:
Aldo J Milone, Alice S Tsao, Althea A Williams, Amy Wyan Mai, Anastasia M Shields, Andrew F Cohen, Andrew M Abramowitz, Ann B Okon, Ann L Demarco, Anne Marie Dubrey, Arduino Frankovic, Arthur F Walker, Arthur G Hurst, Barbara L Williams, Benton M Ketron, Brian J Ryan, Bruce G Cooper, Candace Y Gomez Broughton, Carla A Norris, Carolyn J Cook, Charla L Glenister, Dana A Razzano, Daniel L Aisen, David A Carlson, David A Laplante, David M Mcnew, Denise L Terzian, Dennis E Guilfoyle, PhD, Dipesh K Shah, Donald G Gordon, Dr. Abhijit Raha, PhD, Dr. Robert C Horan, MD, Dr. Sriram Subramaniam, PhD, Elizabeth H Davis, Elizabeth H Slazak, Erin L Nagel, Evelyn Taha, Felix Maldonado, Frank Verni, Gabriel Davila, Gary T Greco, Geoffrey B Ward, Geoffrey K Wong, George C Amedro, Harry J Brewer, Helen B Ricalde, Hilary K Wagner, Iram R Hassan, PhD, Isaac N Baah, Jacobson, James D Bridges, Jerri E Lothrop, Joanne E King, Joanne M Schlossin, Joel R Merriman, Joel R Powers, John A Podsadowski, Johnna L Bleem, José E Meléndez, Jose Ohernandez Guzman, Joseph J Vannelli, Joshua D Lopez, Joy P Matthias, Juan Rjimenez Garcia, Judy Keihl, Juliana M Badalucco, Julie Scoma, Junho Pak, Justin A Boyd, Kara A Scheibner, PhD, Karen L Kosar, Kathryn A Nagy, Kenneth G Klobus, Kerun Hardeo, Kim M Downing, Kimberly Y Smithson, Kwong P Lee, Kyle J Spencer, Lauren E Blaser, Lawrence H Patrick, Lawrence W Farina, LCDR Chad N Thompson, Linda F Murphy, Linda M Sacco, Lisa M Romano, Lisa Mathew, Margaret E Sarles, Marlene L Davis, Mary M Finn, Matthew D Schnittker, Meghan L Fetterly, Meghan L Vanhouse, Michael A Charles, Michael F Skelly, PhD, Michael G Sinkevich, Michael Levin, Michael R Dominick, Michael W Burd, Michelle Yclark Stuart, Mindy M Chou, Mohsen Rajabi Abhari, FDA, Nancy A Saxenian Emmons, Nicholas C Mendiola, Niketa Patel, Parul M Patel, Patricia A Clark, Patricia F Hughes, PhD, Paul E Stein, Paul Mouris, Perez, Peter Abel, Peter E Baker, Peter R Caparelli, Randi Lynn Bodoh, Randi Lynn Spencer, Rashmi Rawat, PhD, Regina T Brown, Richard K Glabach, Robert C Steyert, Robert J Veitch, Saleem A Akhtar, Sarah Forney, Sasha M Latonis, Scott T Ballard, Seongeun Cho (Julia), PhD, Sherona A Ryder, Sonia E Ortiz, Sony Mathews, Sripal R Mada, PhD, Steven J Libal, Steven M Weinman, Susan M Jackson, Syeda N Mahazabin, Tamil Arasu, PhD, Tammy S Notto, Thomas J Arista, Thuy T Nguyen, LCDR, Wayne S Thompson, Wendy M Stone, William C Lubas, William J Leonard, William M Rennells, William P Chilton, Xiaohan Cai, PhD, Yasamin Ameri, Yiying E Chen, Yiyue Zhang (nmi), PhD, Yvesna C Blaise

Russ E Davis's Documents

Publish Date Document Type Title
March, 2002 FDA 483 Response Lotte Biologics USA, LLC - Form 483R, 2002-04-15
May, 2006 EIR Ortho Clinical Diagnostics - EIR, 2006-05-12
March, 2000 EIR Lotte Biologics USA, LLC - EIR, 2000-03-10
September, 2003 FDA 483 G. C. Hanford Manufacturing Co - Form 483, 2003-09-16
March, 2002 EIR GC HANFORD MFG CO - EIR, 2002-03-05
December, 2005 EIR ICON Development Solutions, LLC - EIR, 2005-12-15
September, 2001 FDA 483 Response GC HANFORD MFG CO - Form 483R, 2001-10-04
February, 2003 EIR GC HANFORD MFG CO - EIR, 2003-02-11
April, 2003 FDA 483 GC HANFORD MFG CO - Form 483, 2003-04-04
May, 2005 FDA 483 Jeffery Lancet M.D. - Form 483, 2005-06-15
December, 2005 FDA 483 ICON Development Solutions, LLC - Form 483, 2005-12-15
February, 2001 FDA 483 Bristol-Myers Squibb Co., Inc. - Form 483, 2001-02-01
February, 2003 FDA 483 GC HANFORD MFG CO - Form 483, 2003-02-11
April, 2003 FDA 483 Response GC HANFORD MFG CO - Form 483R, 2003-04-25
March, 2000 FDA 483 Lotte Biologics USA, LLC - Form 483, 2000-03-10
September, 2001 EIR GC HANFORD MFG CO - EIR, 2001-09-07
August, 2003 EIR Bristol-Myers Squibb Co., Inc. - EIR, 2003-08-26
March, 2000 EIR GC HANFORD MFG CO - EIR, 2000-03-30
September, 2004 EIR GC HANFORD MFG CO - EIR, 2004-09-13
May, 2001 EIR Roswell Park Cancer Institute - EIR, 2001-05-02
March, 2002 FDA 483 Lotte Biologics USA, LLC - Form 483, 2002-03-29
April, 2003 EIR GC HANFORD MFG CO - EIR, 2003-04-04
June, 2004 EIR Lotte Biologics USA, LLC - EIR, 2004-06-16
July, 2005 EIR ICON Development Solutions, LLC - EIR, 2005-07-27
June, 2000 EIR GC HANFORD MFG CO - EIR, 2000-06-06
May, 2001 FDA 483 Roswell Park Cancer Institute - Form 483, 2001-05-02
February, 2008 FDA 483 Marietta Corporation dba Voyant Beauty - Form 483, 2008-02-05
June, 2013 FDA 483 Mylan Laboratories Limited - Form 483, 2013-06-27
March, 2000 FDA 483 Response Lotte Biologics USA, LLC - Form 483R, 2000-03-31
November, 2002 EIR ICON Development Solutions, LLC - EIR, 2002-11-19
February, 2006 FDA 483 Kendall, a division of TycoHealthcare Group LP - Form 483, 2006-02-03
February, 2003 FDA 483 Response GC HANFORD MFG CO - Form 483R, 2003-03-04
September, 2004 FDA 483 GC HANFORD MFG CO - Form 483, 2004-09-13
September, 2002 FDA 483 Response Cidec LLC - Form 483R, 2002-11-13
April, 2006 FDA 483 G. C. Hanford Manufacturing Co - Form 483, 2006-05-18
August, 2000 EIR ICON Development Solutions, LLC - EIR, 2000-08-17
October, 2000 FDA 483 Bausch & Lomb Incorporated - Form 483, 2000-10-02
September, 2001 FDA 483 GC HANFORD MFG CO - Form 483, 2001-09-07
February, 2001 EIR Bristol-Myers Squibb Co., Inc. - EIR, 2001-02-01
November, 2001 EIR G. C. Hanford Manufacturing Co - EIR, 2001-11-26
June, 2013 EIR Mylan Laboratories Limited - EIR, 2013-06-27
March, 2002 EIR Lotte Biologics USA, LLC - EIR, 2002-03-29
October, 2000 FDA 483 Response Bausch & Lomb Incorporated - Form 483R, 2000-10-20
August, 2006 EIR Lotte Biologics USA, LLC - EIR, 2024-02-09
September, 2002 FDA 483 Cidec LLC - Form 483, 2002-09-12
August, 2003 FDA 483 Bristol-Myers Squibb Co., Inc. - Form 483, 2003-08-26
August, 2000 FDA 483 ICON Development Solutions, LLC - Form 483, 2000-08-17
September, 2004 FDA 483 Litron Laboratories - Form 483, 2004-09-30
November, 2003 FDA 483 Howard J. Donsky, MD - Form 483, 2003-11-05
March, 2007 FDA 483 GC HANFORD MFG CO - Form 483, 2007-03-16

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more